SEC Info - AstroNova, Inc. - ‘10-Q’ for 7/30/22

Page	(sequential)		(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Controls and Procedures Exhibits Financial Information Financial Statements July 30, 2022 and January 31, 2022 Legal Proceedings Management's Discussion and Analysis of Financial Condition and Results of Operations Notes to the Condensed Consolidated Financial Statements (unaudited) Other Information Quantitative and Qualitative Disclosures about Market Risk Risk Factors Signatures Six Months Ended July 30, 2022 and July 31, 2021 Table of Contents Three and Six Months Ended July 30, 2022 and July 31, 2021 Unaudited Condensed Consolidated Balance Sheets -- July 30, 2022 and January 31, 2022 Unaudited Condensed Consolidated Statements of Cash Flows -- Six Months Ended July 30, 2022 and July 31, 2021 Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity -- Three and Six Months Ended July 30, 2022 and July 31, 2021 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) -- Three and Six Months Ended July 30, 2022 and July 31, 2021 Unaudited Condensed Consolidated Statements of Income -- Three and Six Months Ended July 30, 2022 and July 31, 2021 Unregistered Sales of Equity Securities and Use of Proceeds
1	1st Page – Filing Submission
"	Table of Contents
"	Financial Information
"	Financial Statements
"	Unaudited Condensed Consolidated Balance Sheets -- July 30, 2022 and January 31, 2022
"	Unaudited Condensed Consolidated Statements of Income -- Three and Six Months Ended July 30, 2022 and July 31, 2021
"	Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) -- Three and Six Months Ended July 30, 2022 and July 31, 2021
"	Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity -- Three and Six Months Ended July 30, 2022 and July 31, 2021
"	Unaudited Condensed Consolidated Statements of Cash Flows -- Six Months Ended July 30, 2022 and July 31, 2021
"	Notes to the Condensed Consolidated Financial Statements (unaudited)
"	Management's Discussion and Analysis of Financial Condition and Results of Operations
"	Quantitative and Qualitative Disclosures about Market Risk
"	Controls and Procedures
"	Other Information
"	Legal Proceedings
"	Risk Factors
"	Unregistered Sales of Equity Securities and Use of Proceeds
"	Exhibits
"	Signatures

i false i Q2 i 0000008146 i --01-31 0000008146 2022-02-01 2022-07-30 0000008146 2021-02-01 2021-07-31 0000008146 2022-07-30 0000008146 2022-01-31 0000008146 2022-05-01 2022-07-30 0000008146 2021-05-02 2021-07-31 0000008146 2021-07-31 0000008146 2022-02-01 2022-04-30 0000008146 2021-02-01 2021-05-01 0000008146 2022-09-01 0000008146 2022-03-22 0000008146 2021-01-31 0000008146 2022-04-30 0000008146 2021-05-01 0000008146 alot:TermLoanDueSeptemberThirtyTwoThousandAndTwentyFiveMember 2022-07-30 0000008146 alot:TwoThousandEighteenEquityIncentivePlanMember 2022-07-30 0000008146 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-07-30 0000008146 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-07-30 0000008146 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-07-30 0000008146 us-gaap:CustomerContractsMember alot:MiltopeCorporationMember 2022-07-30 0000008146 alot:RuggedInformationTechnologyEquipmentCorporationMember us-gaap:CustomerContractsMember 2022-07-30 0000008146 alot:TrojanlabelApSMember alot:ExistingTechnologyMember 2022-07-30 0000008146 alot:TrojanlabelApSMember alot:DistributorRelationsMember 2022-07-30 0000008146 us-gaap:CustomerContractsMember alot:HoneywellAssetPurchaseAndLicenseAgreementMember 2022-07-30 0000008146 alot:TwoThousandSevenEquityIncentivePlanMember 2022-07-30 0000008146 us-gaap:RestrictedStockMember alot:TwoThousandFifteenEquityIncentivePlanMember 2022-07-30 0000008146 alot:TermLoanMember 2022-07-30 0000008146 alot:RangeThreeMember 2022-07-30 0000008146 alot:RangeFourMember 2022-07-30 0000008146 alot:RangeFiveMember 2022-07-30 0000008146 alot:TwoThousandEighteenEquityIncentivePlanMember us-gaap:RestrictedStockUnitsRSUMember 2022-07-30 0000008146 alot:TwoThousandEighteenEquityIncentivePlanMember us-gaap:PerformanceSharesMember 2022-07-30 0000008146 alot:TwoThousandEighteenEquityIncentivePlanMember us-gaap:RestrictedStockMember 2022-07-30 0000008146 us-gaap:RestrictedStockUnitsRSUMember 2022-07-30 0000008146 alot:TwoThousandAndTwentyTwoEmployeeStockPurchasePlanMember 2022-07-30 0000008146 alot:HoneywellAssetPurchaseAndLicenseAgreementMember 2022-07-30 0000008146 alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember alot:BeforeAmendementToTheCreditAgreementMember 2022-07-30 0000008146 alot:BankOfAmericaMember alot:TermLoanMember alot:BeforeAmendementToTheCreditAgreementMember 2022-07-30 0000008146 alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2022-07-30 0000008146 alot:TermLoanDueSeptemberThirtyTwoThousandAndTwentyFiveMember 2022-01-31 0000008146 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-01-31 0000008146 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-01-31 0000008146 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-01-31 0000008146 alot:MiltopeCorporationMember us-gaap:CustomerContractsMember 2022-01-31 0000008146 us-gaap:CustomerContractsMember alot:RuggedInformationTechnologyEquipmentCorporationMember 2022-01-31 0000008146 alot:TrojanlabelApSMember alot:ExistingTechnologyMember 2022-01-31 0000008146 alot:DistributorRelationsMember alot:TrojanlabelApSMember 2022-01-31 0000008146 alot:HoneywellAssetPurchaseAndLicenseAgreementMember us-gaap:CustomerContractsMember 2022-01-31 0000008146 country:US 2022-05-01 2022-07-30 0000008146 srt:EuropeMember 2022-05-01 2022-07-30 0000008146 country:CA 2022-05-01 2022-07-30 0000008146 srt:AsiaMember 2022-05-01 2022-07-30 0000008146 alot:CentralAndSouthAmericaMember 2022-05-01 2022-07-30 0000008146 alot:OthersCountriesMember 2022-05-01 2022-07-30 0000008146 alot:HardwareProductsMember 2022-05-01 2022-07-30 0000008146 alot:SuppliesMember 2022-05-01 2022-07-30 0000008146 alot:ServiceAndOtherMember 2022-05-01 2022-07-30 0000008146 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-30 0000008146 us-gaap:CommonStockMember 2022-05-01 2022-07-30 0000008146 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-30 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-05-01 2022-07-30 0000008146 alot:TestAndMeasurementMember 2022-05-01 2022-07-30 0000008146 alot:ProductIdentificationMember 2022-05-01 2022-07-30 0000008146 us-gaap:CorporateNonSegmentMember 2022-05-01 2022-07-30 0000008146 us-gaap:OperatingSegmentsMember alot:ProductIdentificationMember 2022-05-01 2022-07-30 0000008146 us-gaap:OperatingSegmentsMember 2022-05-01 2022-07-30 0000008146 us-gaap:OperatingSegmentsMember alot:TestAndMeasurementMember 2022-05-01 2022-07-30 0000008146 us-gaap:GeneralAndAdministrativeExpenseMember 2022-05-01 2022-07-30 0000008146 alot:CashFlowHedgeMember us-gaap:CrossCurrencyInterestRateContractMember 2022-05-01 2022-07-30 0000008146 us-gaap:OtherExpenseMember us-gaap:RevolvingCreditFacilityMember alot:BankOfAmericaMember 2022-05-01 2022-07-30 0000008146 us-gaap:RevolvingCreditFacilityMember alot:BankOfAmericaMember 2022-05-01 2022-07-30 0000008146 alot:HoneywellAssetPurchaseAndLicenseAgreementMember 2022-05-01 2022-07-30 0000008146 country:US 2021-05-02 2021-07-31 0000008146 srt:EuropeMember 2021-05-02 2021-07-31 0000008146 country:CA 2021-05-02 2021-07-31 0000008146 srt:AsiaMember 2021-05-02 2021-07-31 0000008146 alot:CentralAndSouthAmericaMember 2021-05-02 2021-07-31 0000008146 alot:OthersCountriesMember 2021-05-02 2021-07-31 0000008146 alot:HardwareProductsMember 2021-05-02 2021-07-31 0000008146 alot:SuppliesMember 2021-05-02 2021-07-31 0000008146 alot:ServiceAndOtherMember 2021-05-02 2021-07-31 0000008146 us-gaap:AdditionalPaidInCapitalMember 2021-05-02 2021-07-31 0000008146 us-gaap:CommonStockMember 2021-05-02 2021-07-31 0000008146 us-gaap:TreasuryStockMember 2021-05-02 2021-07-31 0000008146 us-gaap:RetainedEarningsMember 2021-05-02 2021-07-31 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-02 2021-07-31 0000008146 alot:TestAndMeasurementMember 2021-05-02 2021-07-31 0000008146 alot:ProductIdentificationMember 2021-05-02 2021-07-31 0000008146 us-gaap:CorporateNonSegmentMember 2021-05-02 2021-07-31 0000008146 us-gaap:OperatingSegmentsMember alot:ProductIdentificationMember 2021-05-02 2021-07-31 0000008146 us-gaap:OperatingSegmentsMember 2021-05-02 2021-07-31 0000008146 us-gaap:OperatingSegmentsMember alot:TestAndMeasurementMember 2021-05-02 2021-07-31 0000008146 us-gaap:GeneralAndAdministrativeExpenseMember 2021-05-02 2021-07-31 0000008146 us-gaap:CrossCurrencyInterestRateContractMember alot:CashFlowHedgeMember 2021-05-02 2021-07-31 0000008146 alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember us-gaap:OtherExpenseMember 2021-05-02 2021-07-31 0000008146 alot:ForgivenessOfLoanUnderPaycheckProtectionProgrammeMember 2021-05-02 2021-07-31 0000008146 alot:TermLoanDueSeptemberThirtyTwoThousandAndTwentyFiveMember 2022-02-01 2022-07-30 0000008146 alot:RangeThreeMember 2022-02-01 2022-07-30 0000008146 alot:RangeFourMember 2022-02-01 2022-07-30 0000008146 alot:RangeFiveMember 2022-02-01 2022-07-30 0000008146 country:US 2022-02-01 2022-07-30 0000008146 srt:EuropeMember 2022-02-01 2022-07-30 0000008146 country:CA 2022-02-01 2022-07-30 0000008146 srt:AsiaMember 2022-02-01 2022-07-30 0000008146 alot:CentralAndSouthAmericaMember 2022-02-01 2022-07-30 0000008146 alot:OthersCountriesMember 2022-02-01 2022-07-30 0000008146 alot:HardwareProductsMember 2022-02-01 2022-07-30 0000008146 alot:SuppliesMember 2022-02-01 2022-07-30 0000008146 alot:ServiceAndOtherMember 2022-02-01 2022-07-30 0000008146 alot:RestrictedStockAwardAndRestrictedStockUnitMember 2022-02-01 2022-07-30 0000008146 us-gaap:AccumulatedTranslationAdjustmentMember 2022-02-01 2022-07-30 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-02-01 2022-07-30 0000008146 us-gaap:CrossCurrencyInterestRateContractMember 2022-02-01 2022-07-30 0000008146 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-02-01 2022-07-30 0000008146 us-gaap:RestrictedStockUnitsRSUMember 2022-02-01 2022-07-30 0000008146 alot:EmployeeStockPurchasePlanMember 2022-02-01 2022-07-30 0000008146 alot:ProductIdentificationMember 2022-02-01 2022-07-30 0000008146 alot:TestAndMeasurementMember 2022-02-01 2022-07-30 0000008146 us-gaap:CorporateNonSegmentMember 2022-02-01 2022-07-30 0000008146 us-gaap:OperatingSegmentsMember alot:ProductIdentificationMember 2022-02-01 2022-07-30 0000008146 us-gaap:OperatingSegmentsMember alot:TestAndMeasurementMember 2022-02-01 2022-07-30 0000008146 us-gaap:OperatingSegmentsMember 2022-02-01 2022-07-30 0000008146 alot:TwoThousandAndTwentyTwoEmployeeStockPurchasePlanMember 2022-02-01 2022-07-30 0000008146 alot:RestrictedStockAwardMember 2022-02-01 2022-07-30 0000008146 us-gaap:GeneralAndAdministrativeExpenseMember 2022-02-01 2022-07-30 0000008146 alot:CashFlowHedgeMember us-gaap:CrossCurrencyInterestRateContractMember 2022-02-01 2022-07-30 0000008146 us-gaap:RevolvingCreditFacilityMember alot:BankOfAmericaMember us-gaap:OtherExpenseMember 2022-02-01 2022-07-30 0000008146 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2022-02-01 2022-07-30 0000008146 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2022-02-01 2022-07-30 0000008146 alot:GreenWoodCreditUnionMember alot:PaycheckProtectionProgramLoanMember 2022-02-01 2022-07-30 0000008146 us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember srt:MinimumMember 2022-02-01 2022-07-30 0000008146 srt:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:RevolvingCreditFacilityMember 2022-02-01 2022-07-30 0000008146 us-gaap:FederalFundsEffectiveSwapRateMember us-gaap:RevolvingCreditFacilityMember 2022-02-01 2022-07-30 0000008146 us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:RevolvingCreditFacilityMember 2022-02-01 2022-07-30 0000008146 us-gaap:RevolvingCreditFacilityMember 2022-02-01 2022-07-30 0000008146 alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2022-02-01 2022-07-30 0000008146 alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember alot:SecondAmendmentCreditAgreementMember 2022-02-01 2022-07-30 0000008146 alot:HoneywellAssetPurchaseAndLicenseAgreementMember 2022-02-01 2022-07-30 0000008146 country:US 2021-02-01 2021-07-31 0000008146 srt:EuropeMember 2021-02-01 2021-07-31 0000008146 country:CA 2021-02-01 2021-07-31 0000008146 srt:AsiaMember 2021-02-01 2021-07-31 0000008146 alot:CentralAndSouthAmericaMember 2021-02-01 2021-07-31 0000008146 alot:OthersCountriesMember 2021-02-01 2021-07-31 0000008146 alot:HardwareProductsMember 2021-02-01 2021-07-31 0000008146 alot:SuppliesMember 2021-02-01 2021-07-31 0000008146 alot:ServiceAndOtherMember 2021-02-01 2021-07-31 0000008146 alot:ProductIdentificationMember 2021-02-01 2021-07-31 0000008146 alot:TestAndMeasurementMember 2021-02-01 2021-07-31 0000008146 us-gaap:CorporateNonSegmentMember 2021-02-01 2021-07-31 0000008146 us-gaap:OperatingSegmentsMember alot:ProductIdentificationMember 2021-02-01 2021-07-31 0000008146 us-gaap:OperatingSegmentsMember alot:TestAndMeasurementMember 2021-02-01 2021-07-31 0000008146 us-gaap:OperatingSegmentsMember 2021-02-01 2021-07-31 0000008146 alot:TwoThousandAndTwentyTwoEmployeeStockPurchasePlanMember 2021-02-01 2021-07-31 0000008146 us-gaap:GeneralAndAdministrativeExpenseMember 2021-02-01 2021-07-31 0000008146 alot:CashFlowHedgeMember us-gaap:CrossCurrencyInterestRateContractMember 2021-02-01 2021-07-31 0000008146 alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember us-gaap:OtherExpenseMember 2021-02-01 2021-07-31 0000008146 alot:GreenWoodCreditUnionMember alot:PaycheckProtectionProgramLoanMember 2021-02-01 2021-07-31 0000008146 alot:ForgivenessOfLoanUnderPaycheckProtectionProgrammeMember 2021-02-01 2021-07-31 0000008146 us-gaap:SellingAndMarketingExpenseMember 2021-02-01 2021-07-31 0000008146 us-gaap:ResearchAndDevelopmentExpenseMember 2021-02-01 2021-07-31 0000008146 us-gaap:CostOfSalesMember 2021-02-01 2021-07-31 0000008146 us-gaap:AdditionalPaidInCapitalMember 2022-02-01 2022-04-30 0000008146 us-gaap:CommonStockMember 2022-02-01 2022-04-30 0000008146 us-gaap:TreasuryStockMember 2022-02-01 2022-04-30 0000008146 us-gaap:RetainedEarningsMember 2022-02-01 2022-04-30 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-02-01 2022-04-30 0000008146 us-gaap:AdditionalPaidInCapitalMember 2021-02-01 2021-05-01 0000008146 us-gaap:CommonStockMember 2021-02-01 2021-05-01 0000008146 us-gaap:TreasuryStockMember 2021-02-01 2021-05-01 0000008146 us-gaap:RetainedEarningsMember 2021-02-01 2021-05-01 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-02-01 2021-05-01 0000008146 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember 2020-05-03 2020-08-01 0000008146 us-gaap:CashFlowHedgingMember 2020-05-03 2020-08-01 0000008146 alot:HoneywellAssetPurchaseAndLicenseAgreementMember 2018-01-31 0000008146 alot:GreenWoodCreditUnionMember alot:PaycheckProtectionProgramLoanMember 2021-07-31 0000008146 alot:GreenWoodCreditUnionMember alot:PaycheckProtectionProgramLoanMember 2020-05-06 0000008146 alot:CaresActMember 2021-01-01 2021-06-30 0000008146 alot:PurchaseAgreementMember alot:GsndMember stpr:IL alot:AstroMachineLlcMember us-gaap:SubsequentEventMember 2022-08-04 2022-08-04 0000008146 alot:AstroMachineLlcMember stpr:IL us-gaap:SubsequentEventMember alot:GsndMember 2022-08-04 2022-08-04 0000008146 alot:PurchaseAndSaleAgreementMember alot:AstroMachineLlcMember stpr:IL alot:SelakRealEstateLimitedPartnershipMember us-gaap:SubsequentEventMember 2022-08-04 2022-08-04 0000008146 us-gaap:SubsequentEventMember us-gaap:RevolvingCreditFacilityMember alot:BankOfAmericaMember alot:SecondAmendmentCreditAgreementMember 2022-08-04 2022-08-04 0000008146 us-gaap:SubsequentEventMember 2022-08-04 2022-08-04 0000008146 us-gaap:SubsequentEventMember alot:BankOfAmericaMember us-gaap:RevolvingCreditFacilityMember alot:SecondAmendmentCreditAgreementMember 2022-08-04 0000008146 us-gaap:SubsequentEventMember alot:BankOfAmericaMember alot:TermLoanMember alot:SecondAmendmentCreditAgreementMember alot:AdditionalTermLoanAvailedMember 2022-08-04 0000008146 alot:AstroMachineLlcMember stpr:IL us-gaap:SubsequentEventMember alot:GsndMember 2022-08-04 0000008146 alot:PurchaseAndSaleAgreementMember stpr:IL alot:AstroMachineLlcMember alot:SelakRealEstateLimitedPartnershipMember us-gaap:SubsequentEventMember srt:IndustrialPropertyMember 2022-08-04 0000008146 alot:PurchaseAndSaleAgreementMember stpr:IL alot:AstroMachineLlcMember alot:SelakRealEstateLimitedPartnershipMember us-gaap:SubsequentEventMember us-gaap:LandMember 2022-08-04 0000008146 alot:TermLoanDueSeptemberThirtyTwoThousandAndTwentyFiveMember 2022-01-31 2022-01-31 0000008146 alot:BankOfAmericaMember srt:MaximumMember alot:TermLoanMember 2021-03-24 0000008146 alot:BankOfAmericaMember alot:TermLoanMember 2021-03-24 0000008146 us-gaap:CrossCurrencyInterestRateContractMember 2020-07-30 2020-07-30 0000008146 alot:CaresActMember 2021-07-01 2021-07-30 0000008146 alot:CaresActMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-03-22 2022-03-22 0000008146 alot:HoneywellAssetPurchaseAndLicenseAgreementMember 2018-01-31 2018-01-31 0000008146 us-gaap:CommonStockMember 2022-07-30 0000008146 us-gaap:AdditionalPaidInCapitalMember 2022-07-30 0000008146 us-gaap:RetainedEarningsMember 2022-07-30 0000008146 us-gaap:TreasuryStockMember 2022-07-30 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-30 0000008146 us-gaap:CommonStockMember 2021-07-31 0000008146 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0000008146 us-gaap:RetainedEarningsMember 2021-07-31 0000008146 us-gaap:TreasuryStockMember 2021-07-31 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-31 0000008146 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-31 0000008146 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-31 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-31 0000008146 alot:RestrictedStockAwardAndRestrictedStockUnitMember 2022-01-31 0000008146 alot:RestrictedStockAwardAndRestrictedStockUnitMember 2022-07-30 0000008146 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-30 0000008146 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-30 0000008146 us-gaap:CommonStockMember 2022-01-31 0000008146 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0000008146 us-gaap:RetainedEarningsMember 2022-01-31 0000008146 us-gaap:TreasuryStockMember 2022-01-31 0000008146 us-gaap:CommonStockMember 2022-04-30 0000008146 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0000008146 us-gaap:RetainedEarningsMember 2022-04-30 0000008146 us-gaap:TreasuryStockMember 2022-04-30 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-30 0000008146 us-gaap:CommonStockMember 2021-01-31 0000008146 us-gaap:AdditionalPaidInCapitalMember 2021-01-31 0000008146 us-gaap:RetainedEarningsMember 2021-01-31 0000008146 us-gaap:TreasuryStockMember 2021-01-31 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-31 0000008146 us-gaap:CommonStockMember 2021-05-01 0000008146 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 0000008146 us-gaap:RetainedEarningsMember 2021-05-01 0000008146 us-gaap:TreasuryStockMember 2021-05-01 0000008146 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 iso4217:USD xbrli:shares xbrli:pure utr:Year utr:sqft utr:acre iso4217:USD xbrli:shares alot:Segment

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM

i 10-Q

(Mark One)

i ☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended i July 30, i 2022 /

i ☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number

i 0-13200

i AstroNova, Inc.

(Exact name of registrant as specified in its charter)


i Rhode Island		i 05-0318215
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

i 600 East Greenwich Avenue, i West Warwick, i Rhode Island		i 02893
(Address of principal executive offices)		(Zip Code)

( i 401)

i 828-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
i Common Stock, $.05 Par Value	i ALOT	i NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). i Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.



Large accelerated filer	☐	i Accelerated filer	☒

Non-accelerated filer	☐	Smaller reporting company	i ☒

		Emerging growth company	i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act) Yes

☐ No i ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of the registrant’s common stock, $.05 par value per share, outstanding as of September

, 2022 was i 7,346,758.

Table of Contents

ASTRONOVA, INC.

INDEX


		Page No.
Part I.	Financial Information
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets – July 30, 2022 and January 31, 2022		3
	Unaudited Condensed Consolidated Statements of Income — Three and Six Months Ended July 30, 2022 and July 31, 2021		4
	Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) — Three and Six Months Ended July 30, 2022 and July 31, 2021		5
	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity — Three and Six Months Ended July 30, 2022 and July 31, 2021		6
	Unaudited Condensed Consolidated Statements of Cash Flows — Six Months Ended July 30, 2022 and July 31, 2021		7
	Notes to the Condensed Consolidated Financial Statements (unaudited)		8-24
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		24-33
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		34
Item 4.	Controls and Procedures		34
Part II.	Other Information
Item 1.	Legal Proceedings		34
Item 1A.	Risk Factors		34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		34
Item 6.	Exhibits		35
Signatures			36

Table of Contents

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation industries.

Our business consists of i two segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The PI segment includes specialty printing systems and related supplies sold under the QuickLabel

, TrojanLabel

, and GetLabels

™

brand names. The T&M segment

consists of

our line of aerospace products, including flight deck printers, networking hardware, and related accessories as well as test and measurement data acquisition systems sold under the AstroNova

brand name.

PI products sold under the QuickLabel, TrojanLabel and GetLabels brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding, and labeling solutions to a wide array of industries. The PI segment offers a variety of digital color label tabletop printers,

direct-to-package

printers, high-volume presses, and specialty original equipment manufacturer (“OEM”) printing systems, as well as a wide range of label, tag and flexible packaging material substrates and other supplies, including ink and toner, allowing customers to mark, track, protect and enhance the appearance of their products. In the T&M segment, we have a long history of using our technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers, as well as airborne networking hardware for the aerospace market. In addition, the T&M segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats.

Our PI products are sold by direct field salespersons as well as independent dealers and representatives, while our T&M products are sold predominantly through direct sales and manufacturers’ representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in PI products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third-party contractors. Additionally, we utilize over 200 independent dealers and representatives selling and marketing our products in over 60 countries.

Unless otherwise indicated, references to “AstroNova”, “we,” “our,” and “us” in this Quarterly Report on

Form 10-Q

refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form

10-K

for the fiscal year ended January 31, 2022.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, including those that require consideration of forecasted financial information, in the context of the unknown future impacts of the continuing

COVID-19

pandemic, using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters, including our expectations at the time regarding the duration, scope, and severity of the

COVID-19

pandemic. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year’s financial statements have been reclassified to conform to the current year’s presentation.

Table of Contents

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Note 2 – Summary of Significant Accounting Policies Update

The accounting policies used in preparing the condensed consolidated financial statements in this Form

10-Q

are the same as those used in preparing our consolidated financial statements included in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2022.

Recently Adopted Accounting Pronouncements

No new accounting pronouncements, issued or effective during the first six months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

/ i

Note 3 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems, and airborne printers and networking hardware used in the flight deck and cabin of military, commercial, and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets

Three Months Ended

Six Months Ended

(In thousands)

United States

i 19,044

i 17,181

i 38,695

i 33,874

Europe

i 7,883

i 7,826

i 15,301

i 16,425

Canada

i 2,225

i 1,491

i 4,080

i 3,037

Asia

i 1,789

i 1,964

i 2,726

i 3,049

Central and South America

i 1,023

i 995

i 1,911

i 1,756

Other

i 295

i 388

i 556

i 782

Total Revenue

i 32,259

i 29,845

i 63,269

i 58,923

Major product

types:

Three Months Ended

Six Months Ended

(In thousands)

Hardware

i 8,637

i 7,878

i 17,937

i 15,525

Supplies

i 19,166

i 18,678

i 37,111

i 36,888

Service and Other

i 4,456

i 3,289

i 8,221

i 6,510

Total Revenue

i 32,259

i 29,845

i 63,269

i 58,923

/ /

Table of Contents

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.

Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were $ i 281,000 and $ i 262,000 at July 30, 2022, and January 31, 2022, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. The

increase

in the deferred revenue balance during the six months ended July 30, 2022, is due to cash payments received in advance of satisfying performance obligations in the current period, offset by $ i 177,000 of revenue recognized during the period that was included in the deferred revenue balance at January 31, 2022.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized over the remaining useful life of these contracts, which we currently estimate to be approximately i 19 years as of July 30, 2022. The balance of these contract assets at January 31, 2022, was $ i 1.3 million, and in the first quarter of the current year, we incurred an additional $ i 0.1 million in contract costs that will be amortized over i 19 years.

During the three and six months ended July 30, 2022, we amortized contract costs of

$ i 19,000 and $ i 37,000,

respectively.

The balance of deferred incremental direct costs net of accumulated amortization at
July 30, 2022, was $ i 1.4 million, of which $ i 0.1 million is reported in other current assets and $ i 1.3 million is reported in other assets in the accompanying condensed consolidated balance sheet.

Note 4 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards, and restricted stock units outstanding during the period. i A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

Three Months Ended

Six Months Ended

Weighted Average Common Shares Outstanding – Basic

i 7,309,716

i 7,208,834

i 7,286,735

i 7,176,940

Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units

i 38,230

i 119,724

i 67,972

i 120,178

Weighted Average Common Shares Outstanding – Diluted

i 7,347,946

i 7,328,558

i 7,354,707

i 7,297,118

For the three and six months ended July 30, 2022, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of i 612,116 and i 586,084

respectively. For

the three and six months ended July 31, 2021, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of i 189,827 and i 484,748

respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

Table of Contents

Note 5 – Intangible Assets

Intangible assets are as follows:

July 30, 2022

January 31, 2022

(In thousands)

Gross
Carrying
Amount

Accumulated
Amortization

Currency
Translation
Adjustment

Net
Carrying
Amount

Gross
Carrying
Amount

Accumulated
Amortization

Currency
Translation
Adjustment

Net
Carrying
Amount

Miltope:

Customer Contract Relationships

i 3,100

( i 2,646

)

—

i 454

i 3,100

( i 2,515

)

—

i 585

RITEC:

Customer Contract Relationships

i 2,830

( i 1,590

)

—

i 1,240

i 2,830

( i 1,557

)

—

i 1,273

TrojanLabel:

Existing Technology

i 2,327

( i 1,929

)

i 73

i 471

i 2,327

( i 1,767

)

i 127

i 687

Distributor Relations

i 937

( i 543

)

i 5

i 399

i 937

( i 498

)

i 46

i 485

Honeywell:

Customer Contract Relationships

i 27,243

( i 11,493

)

—

i 15,750

i 27,243

( i 11,073

)

—

i 16,170

Intangible Assets, net

i 36,437

( i 18,201

)

i 78

i 18,314

i 36,437

( i 17,410

)

i 173

i 19,200

There were i i no / impairments

to intangible assets during the periods ended July 30, 2022, and July 31, 2021.

With respect to the acquired intangibles included in the table above, amortization expense of $ i i 0.4 / million has been included in the condensed consolidated statements of income for each of the three months ended July 30, 2022, and July 31, 2021. Amortization expense of $ i 0.8 million and $ i 1.4 million related to the above-acquired intangibles has been included in the accompanying condensed consolidated statement of income for the six months ended July 30, 2022, and July 31, 2021, respectively.

Estimated amortization expense for the next five fiscal years is as follows:


(In thousands)	Remaining 2023		2024		2025		2026		2027

Estimated amortization expense	$	i 792	$	i 1,645	$	i 997	$	i 997	$	i 997

/ / i

Note 6 – Inventories

Inventories are stated at the lower of cost (standard and average methods) and net realizable value and include material, labor, and manufacturing overhead. The components of inventories are as follows:


(In thousands)	July 30, 2022			January 31, 2022

Materials and Supplies	$	i 27,504		$	i 22,709
Work-In-Process		i 1,160			i 1,489
Finished Goods		i 23,369			i 19,718

		i 52,033			i 43,916
Inventory Reserve		( i 10,306	)		( i 9,307	)

	$	i 41,727		$	i 34,609

/ /

Table of Contents

Note 7 – Credit Agreement and Debt

On March 24, 2021, we entered into a First Amendment to our Amended & Restated Credit Agreement as of July 30, 2020 (the “Existing Credit Agreement”) with Bank of America, N.A., as lender (the “Lender”), and our subsidiaries, ANI ApS and TrojanLabel. The Amended & Restated Credit Agreement, which we entered into on July 30, 2020, amended and restated the Credit Agreement dated as of February 28, 2017, by and among us, ANI ApS and TrojanLabel and the Lender.

The

Existing

Credit Agreement provides for (i) a term loan in the principal amount of $ i 10.0 million, and (ii) a $ i 22.5 million revolving credit facility available for general corporate purposes.

The Existing

Credit Agreement requires that the term loan be paid in quarterly installments on the last day of each of our fiscal quarters with the final payment due on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the revolving credit facility will terminate. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The Existing

Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $ i 10.0 million, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.

The interest rates under the Existing Credit Agreement, as amended by the December 14, 2021 LIBOR Transition Amendment,

are as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the BSBY Rate as defined in the LIBOR
Amendment (or in the case of revolving credit loans denominated in Pounds Sterling, Euros or another currency other than U.S. Dollars, the SONIA
Rate as defined in the LIBOR

Amendment, EURIBOR

Rate as defined in the LIBOR Amendment, or the applicable quoted rate, respectively), plus a
margin that varies within a range of i 1.60% to i 2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus i 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the BSBY Rate, SONIA Rate, EURIBOR Rate or other applicable quoted rate plus i 1.00% or (iv) i 0.50%, plus a margin that varies within a range of i 0.60% to i 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of i 0.15% and i 0.30% based on our consolidated leverage ratio.

The loans under the Existing Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Existing Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

We must comply with various customary financial and

non-financial

covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on our capital stock, to repurchase or to acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter our capital structure, to make investments and loans, to change the nature of our business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Existing Credit Agreement, certain of which provisions were modified by the First Amendment.

Table of Contents

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Existing Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Existing Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests we hold in ANI ApS, in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island.

Summary of Outstanding Debt

Revolving Credit Facility

During

the first six months of the current year, we borrowed $ i 4.5 million on our revolving line of credit. The balance outstanding under the revolving line of credit bore interest at a weighted average rate of i 5.17% and i 4.79% for the three and six months ended July 3

, 2022, and we incurred $ i 45,000 and $ i 69,000 for interest on this obligation during the three and six months ended July 30, 2022.

Additionally, during the six months ended July 30, 2022, we incurred $ i 20,000 of commitment fees on the undrawn portion of our revolving credit facility. At

July 31, 2021, there was i no balance outstanding on the revolving line of credit, and i i no / interest was incurred for the three and six months ended July 31, 2021.

incurred $ i 30,000 of commitment fees on the undrawn portion of our revolving credit

facility for the six months ended July 31, 2021.

Both the interest expense and commitment fees are included as interest expense in the accompanying condensed consolidated income statement for all periods presented. At July 30, 2022, there is $ i 18.0 million remaining available for borrowing under the revolving line of credit.

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	July 30, 2022			January 31, 2022

USD Term Loan ( i i 3.45% as of July 30, 2022, and i 2.35% as of January 31, 2022); maturity date of i i September 30, 2025 / /	$	i 9,000		$	i 9,250
Debt Issuance Costs, net of accumulated amortization		( i 83	)		( i 96	)
Current Portion of Term Loans		( i 1,000	)		( i 1,000	)

Long-Term Debt	$	i 7,917		$	i 8,154

During the three and six months ended July 30, 2022, we recognized $ i 65,000 and $ i 118,000 of interest expense on debt, respectively, which

included in interest expense in the accompanying condensed consolidated income statement. During the three and six months ended July 31, 2021, we recognized $ i 65,000 and $ i 179,000 of interest expense on debt, respectively, which

included in interest expense in the accompanying condensed consolidated income statement.

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of July 30, 2022, is as follows:


(In thousands)
Fiscal 2023, remainder	$	i 750
Fiscal 2024		i 1,000
Fiscal 2025		i 1,250
Fiscal 2026		i 6,000

	$	i 9,000

Table of Contents

Note 8 – Paycheck Protection Program Loan

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $ i 4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES A

ct”).

Table of Contents

i The PPP Loan, which would have been set to mature on i May 6, 2022, was unsecured and bore interest at a rate of i 1.0% per annum accruing from the loan date / and

would have been

payable monthly. i No payments were due on the PPP Loan until the date on which the lender determined the amount of the PPP Loan that was eligible for forgiveness.

On June 15, 2021, Greenwood

notified us that the SBA approved our application for forgiveness of the entire $ i 4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $ i 4.5 million gain on extinguishment of debt in the accompanying condensed consolidated income statement for the three and six months ended July 31, 2021.

Note 9 – Derivative Financial Instruments and Risk Management

In 2017, we entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and an interest rate swap to manage the interest rate risk associated with our variable rate term loan borrowing. Both swaps were designated as cash flow hedges of floating-rate borrowings.

Our cross-currency interest rate swap agreement effectively modified our exposure to interest rate risk and foreign currency exchange rate risk by converting our floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Kroner for the term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Kroner, as well as exchanges of principal at the inception spot rate, over the life of the term loan.

The interest rate swap agreement effectively modified our exposure to interest rate risk by effectively converting our floating-rate term-loan debt to fixed-rate debt, thus reducing the impact of interest-rate changes on future interest expense. This swap involved the receipt of floating rate amounts in U.S. Dollars in exchange for fixed rate payments in U.S. dollars over the life of the term loan.

On July 30, 2020, we

terminated these two swaps. The terms of the A&R Credit Agreement caused those swaps to cease to be effective hedges of the underlying exposures. The termination of the swaps was contracted immediately prior to the end of the second quarter of fiscal 2021 at a cash cost of approximately $ i 0.7 million which was settled in the third quarter of fiscal 2021. Upon termination, the remaining balance of $ i 58,000 in accumulated other comprehensive loss related to the cross-currency interest rate swap was reclassified into earnings as the forecasted foreign currency interest payments will not occur. The remaining balance in accumulated other comprehensive loss related to the interest rate swap of $

i 0.2 million is being amortized into earnings through the original term of the hedge relationship as the underlying floating interest rate debt still exists.

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three and six months ended July 30, 2022 and July 31, 2021:

Three Months Ended

Amount of Gain (Loss)
Recognized in OCI
on Derivative

Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into
Income

Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income

Cash Flow Hedge

(In thousands)

Swap contracts

i —

i Other Expense

( i 20

)

( i 20

)

/ /

Table of Contents

Six Months Ended

Amount of Gain (Loss)
Recognized in OCI
on Derivative

Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into Income

Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income

Cash Flow Hedge

(In thousands)

Swap contracts

i —

i Other Expense

( i 40

)

( i 40

)

At July 30, 2022, we expect to reclassify approximately $ i 20,000 of net losses on the frozen OCI balance associated with the terminated interest rate swap from accumulated other comprehensive loss to earnings during the next 12 months due to the payment of variable interest associated with the floating interest rate debt.

Note 10 – Employee Retention Credit

The CARES Act provides an employee retention credit (“ERC”) that was a refundable tax credit against certain employer taxes. On December 27, 2020, Congress enacted the Taxpayer Certainty and Disaster Tax Relief Act of 2020, which amended and extended ERC availability under Section 2301 of the CARES Act. Before the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we were ineligible for the ERC because we received the PPP Loan. Following the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we and other businesses that received loans under that program became retroactively eligible for the ERC.

As a result of the foregoing legislation, we became eligible to claim a refundable tax credit against the employer’s share

of Social Security taxes equal to seventy percent ( i 70%) of the qualified wages that we paid to our employees between December 31, 2020 and June 30, 2021. Qualified

wages were limited

to $ i 10,000 per employee per calendar quarter in 2021 for a maximum ERC per employee of $ i 7,000 per calendar quarter in 2021.

We evaluated our eligibility for the ERC in the second quarter of calendar year 2021. In order to qualify for the ERC, we needed to experience a i 20% reduction in gross receipts from either (1) the same quarter in calendar year 2019 or (2) the immediately preceding quarter to the corresponding calendar quarter in 2019. We determined that we qualified for the employee retention credit under the first scenario for wages paid in calendar year 2020 and the first calendar quarter of 2021. In the second quarter of fiscal 2022, we amended certain payroll tax filings and applied for a refund of $ i 3.1 million. Since there is no US GAAP guidance for

for-profit

business entities that receive government assistance that is not in the form of a loan, an income tax credit or revenue from a contract with a customer, we determined the appropriate accounting treatment by analogy to other guidance. We accounted for the employee retention credit by analogy to International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, of International Financial Reporting Standards (IFRS). Under an IAS 20 analogy, a business entity would recognize the credit on a systematic basis over the periods in which the entity recognizes the payroll expenses for which the grant (i.e., tax credit) is intended to compensate when there is reasonable assurance (i.e., it is probable) that the entity will comply with any conditions attached to the grant and the grant (i.e., tax credit) will be received.

We recorded a $ i 3.1 million receivable in the second quarter of fiscal 2022 for the ERC receivable and recognized a reduction in employer payroll taxes which was allocated to the financial statement captions from which the employee’s taxes were originally incurred. As a result, we recorded a reduction in expenses of $ i 1.7 million in cost of revenue, $ i 0.8 million in selling and marketing, $ i 0.3 million in research and development and $ i 0.3 million in general and administrative in the accompanying condensed consolidated income statement for the three and six month periods ended July 31, 2021. On March 22, 2022, we received payment of the $ i 3.1 million ERC.

Table of Contents

Note 11 – Royalty Obligation

In fiscal 2018, we entered into an Asset Purchase and License Agreement with Honeywell to acquire an exclusive, perpetual, worldwide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $ i 15.0 million, to be paid over i ten years, based on gross revenues from the sales of the printers, paper, and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, and product sold or service provided, and range from single-digit to

mid-double-digit

percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of i 2.8%, which is based on the estimated

after-tax

cost of debt for similar companies. As of July 30, 2022, we had paid an aggregate of $ i 8.5 million of the guaranteed minimum royalty obligation. At July 30, 2022, the current portion of the outstanding guaranteed minimum royalty obligation of $ i 1.9 million is to be paid over the next twelve months and is reported as a current liability, and the remainder of $ i 3.6 million is reported as a long-term liability on our condensed consolidated balance sheet. For the three and six month periods ended July 30, 2022, we incurred $ i 0.3 million and $ i 0.6 million, respectively, in excess royalty expenses which are included in the cost of revenue in our condensed consolidated statements of income. A total of $ i 0.5 million in excess royalties was paid during the current fiscal year, and there are $ i 0.3 million in excess royalty payables due as a result of this agreement for the period ended July 30, 2022.

/ i

Note 12 – Leases

We enter into lease contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of one to six years, some of which include options to extend the lease term for periods of up to five years when it is reasonably certain that we will exercise such options.

Balance sheet and other information related to our leases is as follows:

Operating Leases

(In thousands)

Balance Sheet Classification

July 30,
2022

January 31,
2022

Lease Assets

Right of Use Assets

i 887

i 1,094

Lease Liabilities – Current

Other Liabilities and Accrued Expenses

i 302

i 327

Lease Liabilities – Long Term

Lease Liabilities

i 627

i 808

Table of Contents

Lease cost information is as follows:

Three Months Ended

Six Months Ended

Operating Leases

(In thousands)

Statement of Income Classification

July 30,
2022

Operating Lease Costs

General and Administrative Expense

i 104

i 200

Three Months Ended

Six Months Ended

Operating Leases

(In thousands)

Statement of Income Classification

July 31,
2021

Operating Lease Costs

General and Administrative Expense

i 124

i 260

/ i

Maturities of operating lease liabilities are as follows:


(In thousands)	July 30, 2022
Fiscal 2023, remaining	$	i 151
Fiscal 2024		i 293
Fiscal 2025		i 192
Fiscal 2026		i 146
Fiscal 2027		i 140
Thereafter		i 86

Total Lease Payments		i 1,008
Less: Imputed Interest		( i 79	)

Total Lease Liabilities	$	i 929

As of July 30, 2022, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are i 4.6 years and i 3.85%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Table of Contents

Supplemental cash flow information related to leases is as follows:


	Three Months Ended		Six Months Ended
(In thousands)	July 30, 2022		July 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	i 79	$	i 162


	Three Months Ended		Six Months Ended
(In thousands)	July 31, 2021		July 31, 2021

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	i 93	$	i 185

/ i

Note 13 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:

(In thousands)

Foreign Currency
Translation
Adjustments

Cash
Flow
Hedges

Total

Balance at January 31, 2022

( i 1,701

)

( i 47

)

( i 1,748

)

Other Comprehensive Loss before reclassification

( i 1,368

)

—

( i 1,368

)

Amounts reclassified from AOCL to Earnings

—

i 32

Other Comprehensive Income (Loss)

( i 1,368

)

i 32

( i 1,336

)

Balance at July 30, 2022

( i 3,069

)

( i 15

)

( i 3,084

)

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German, Danish and Shanghai subsidiaries.

/ i

Note 14 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options,

non-qualified

stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs). The 2018 Plan authorizes the issuance of up to i 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited,

canceled

, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were i 129,363 unvested RSUs; i 128,793 unvested PSUs; i 21,172 unvested RSAs and options to purchase an aggregate of i 135,500 shares outstanding as of July 30, 2022.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of July 30, 2022, options to purchase an aggregate of i 308,274 shares were outstanding under the 2007 Plan and options to purchase an aggregate of i 135,325 shares were outstanding under the 2015 Plan.

We also have a

Non-Employee

Director Annual Compensation Program (the “Program”), under which each of our

non-employee

directors automatically receives a grant of restricted stock on the date of their

re-election

to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2023 is $ i 65,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.

Table of Contents

Share-based compensation expense was recognized as follows:

Three Months Ended

Six Months Ended

(In thousands)

Stock Options

i 1

i 57

i 7

i 162

Restricted Stock Awards and Restricted Stock Units

i 234

i 408

i 562

i 778

Employee Stock Purchase Plan

i —

i 4

i 3

i 7

Total

i 235

i 469

i 572

i 947

Stock Options

Aggregated information regarding stock option activity for the six months ended July 30, 2022 is summarized below:


	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2022		i 598,043		$	i 14.67
Exercised		( i 11,444	)		i 9.51
Forfeited		( i 5,100	)		i 15.38
Expired		( i 2,400	)		i 8.09

Outstanding at July 31, 2021		i 579,099		$	i 14.79

/ i

Set forth below is a summary of options outstanding at July 30, 2022:

Outstanding

Exercisable

Range of

Exercise prices

Number
of
Options

Weighted-
Average
Exercise
Price

Weighted-
Average
Remaining
Contractual Life

Number
of
Options

Weighted-
Average
Exercise
Price

Weighted
Average
Remaining
Contractual
Life

$ i 5.00- i 10.00

i 25,000

i 7.91

i 0.1

i 25,000

i 7.91

i 0.1

$ i 10.01- i 15.00

i 339,549

i 13.62

i 3.4

i 340,549

i 13.62

i 3.4

$ i 15.01- i 20.00

i 214,550

i 17.45

i 5.3

i 214,550

i 17.45

i 5.3

i 579,099

i 14.79

i 4.0

i 579,099

i 14.79

i 4.0

There were i i no / stock options granted in either fiscal 2022 or during the six months ended July 30, 2022, and as of July 30

2022, there was

unrecognized compensation expense related to stock options.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU and RSA activity for the six months ended July 30, 2022 is summarized below:


	RSAs & RSUs			Weighted Average Grant Date Fair Value

Outstanding at January 31, 2022		i 199,342		$	i 12.63
Granted		i 163,009			i 12.77
Vested		( i 81,923	)		i 13.42
Forfeited		( i 1,100	)		i 11.77

Outstanding at July 30, 2022		i 279,328		$	i 12.48

of July 30, 2022, there was approximately $ i 1.7 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of i 1.2 years.

Table of Contents

Employee Stock Purchase Plan

On June 7, 2022, we adopted the AstroNova Inc., 2022 Employee Stock Purchase Plan (“2022 ESPP”) to replace our previous Employee Stock Purchase Plan (the “Prior ESPP”). The 2022 ESPP allows eligible employees to purchase shares of common stock at

a i 15%

discount from fair value on the first or last day of an offering period, whichever is less. A total

of i 40,000

shares were reserved for issuance under this plan. No shares were purchased under the 2022 ESSP during the six month period ended July 30, 2022. During the six month periods ended July 30, 2022 and July 31, 2021, there

were i 1,550 and i 3,899

shares, respectively, purchased under the Prior ESPP, and no additional purchases may be made under that plan. As of July 30, 2022

, i 40,000 shares

remain available for purchase under the 2022 ESPP.

Note 15 – Income Taxes

Our effective tax rates for the period are as follows:


	Three Months Ended			Six Months Ended
Fiscal 2023		i 27.4	%		i 21.7	%
Fiscal 2022		i 9.1	%		i 5.8	%

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted

pre-tax

income and facts known at that time. The estimated annual effective tax rate is applied to the

year-to-date

pre-tax

income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended July 30, 2022, we recognized an income tax expense of $

i 0.2

million

. The effective tax rate in this period was directly impacted by our jurisdictional mix of earnings and a $ i 13,000 tax expense relating to a revaluation of deferred taxes. During the three months ended July 31, 2021, we recognized an income tax expense of $ i 0.7 million. The effective tax rate in this period was directly impacted by a $ i 1.1 million tax benefit from the forgiveness of the PPP Loan, a $ i 0.1 million tax benefit arising from a windfall related to our stock compensation and a $ i 32,000 tax benefit related to return to provision adjustments from foreign tax returns filed in the quarter. The PPP Loan forgiveness recognized during the three months ended July 31, 2021, is excluded from federal taxable income under Section 1106(i) of the CARES Act

During the six months ended July 30, 2022, we recognized an income tax expense of $

i 0.3

million

. The effective tax rate in this period was directly impacted by our jurisdictional mix of earnings, a $ i 38,000

tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions,

a $ i 21,000

tax benefit arising from windfall tax expense related to our stock, and

a $ i 13,000 tax

expense relating to a revaluation of deferred taxes. During the six months ended July 31, 2021, we recognized an income tax expense

of $ i 0.5 million. The effective tax rate in this period was directly impacted by a $ i 1.1 million tax benefit from the forgiveness of the PPP loan, a $ i 0.3

million tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions,

a $ i 0.1

million tax benefit arising from windfall tax expense related to our stock, and

a $ i 32,000

tax benefit related to return to provision adjustments from foreign tax returns filed in the year. The PPP loan forgiveness recognized during the six months ended July 31, 2021, is excluded from taxable income under Section 1106(i) of the CARES Act.

Table of Contents

Note 17 – Fair Value

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

July 30, 2022

Fair Value Measurement

(In thousands)

Level 1

Level 2

Level 3

Total

Carrying
Value

Long-Term debt and related current maturities

—

i 9,011

i 9,000

January 31, 2022

Fair Value Measurement

(In thousands)

Level 1

Level 2

Level 3

Total

Carrying
Value

Long-Term debt and related current maturities

—

i 9,255

i 9,250

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

/ i

Note 18 – Subsequent Event

August

2022

, we acquired Astro Machine LLC (“Astro Machine”), an Elk Grove Village, Illinois-based manufacturer of printing equipment, including labelers, tabbers, conveyors, and envelope feeders for aggregate consideration of $

i 17.1

million.

The

acquisition was accomplished pursuant to an Equity Interest Purchase Agreement dated as of August 4, 2022 (the “Purchase Agreement”) by and among us, GSND Holding Corporation (“GSND”), the parent company of Astro Machine, and Astro Machine. Pursuant to the Purchase Agreement, we purchased i 100% of the issued and outstanding equity interests of Astro Machine from GSND for a purchase price, payable in cash, of $ i 15.6 million. We obtained a representation and warranty insurance policy and placed $ i 300,000 of the purchase price into an escrow account, which pursuant to the terms and conditions of the Purchase Agreement, are our sole recourse for breaches of representations and warranties by GSND. Upon the closing of the transaction, Astro Machine became a wholly owned subsidiary of AstroNova,

Inc.

This

transaction is a business combination and will be accounted for using the acquisition method. The purchase price of Astro Machine will be allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair value at the acquisition date. Any excess of the purchase price over the fair value of the net identified assets acquired and liabilities assumed will be recorded as goodwill. Transaction costs related to the transaction will be expensed as incurred. We are currently preparing the valuations and other procedures necessary to determine the purchase price allocation and will record our initial fair value estimates and the results of operations of Astro Machine since the acquisition date in our condensed consolidated financial statement for the third quarter of fiscal 2023.

Concurrently

with the signing of the Purchase Agreement, our newly acquired subsidiary, Astro Machine, entered into a Purchase and Sale Agreement with Selak Real Estate Limited Partnership (“SRE”), pursuant to which Astro Machine purchased certain real property assets of SRE for a purchase price, paid in cash, of $ i 1.5

mil

lion

. These real estate assets are comprised of a i 34,460 square foot industrial manufacturing building (including offices) on i 1.26 acres of land which is Astro Machine’s principal place of business.

In connection with the purchase of Astro Machine, on August 4, 2022, we entered into a Second Amendment to Amended and Restated Credit Agreement (the “Second Amendment”) with the Lender. The Second Amendment amended the Existing Credit Agreement (the “Amended Credit Agreement”).

The

Amended Credit Agreement provides for (i) a new term loan in the principal amount of $ i 6.0 million, which term loan is in addition to the existing term loan outstanding under the Existing Credit Agreement in the principal amount of $ i 9.0 million as of the effective date of the Second Amendment, and (ii) an increase in the aggregate principal amount of the revolving credit facility available from $ i 22.5 million to $ i 25.0 million. At the closing of the Second Amendment, we borrowed the entire $ i 6.0

million term loan and $ i 12.4 million under the revolving credit facility, and the proceeds of such borrowings were used in part to pay the purchase price payable under the Purchase Agreement and certain related transaction costs. We have since repaid $ i 1.0 million of the amount borrowed under the revolving credit facility.

COVID-19

Update—Overview

All of our global operations have been materially adversely affected by the worldwide

COVID-19

pandemic during the past two years. We expect this adverse impact to continue to a degree that we cannot predict.

We made significant modifications to our global operations because of the

COVID-19

pandemic. We initially required most

non-production

related team members to work remotely. Although this is no longer required for health and safety reasons, for many of our team members, remote work has become a preference and we believe we have to a large degree successfully adapted to it through the use of technology and changed management practices, but further adaptations, may be required. We expect that our operations and modalities of

on-site

and remote work will be impacted permanently, as will our increased safety protocols and the other adaptations undertaken during the pandemic, but our practices and plans are still developing, and we cannot predict the results yet.

Since the

COVID-19

pandemic began we have experienced difficulties in obtaining raw materials and components for our products. Some of the structural dislocations in the global economy caused by the pandemic are deepening and prolonging these difficulties. We have had to incur additional costs, such as expedited and express shipping fees (i.e., air rather than ocean freight). These difficulties have also negatively impacted our efficiency, delayed shipments, and caused product shortages

We are currently monitoring the worldwide delays in transit time as freight carriers continue to experience significant delays in overseas shipments. We are addressing these issues through long-range planning and procuring higher inventory on severely allocated items to help mitigate potential shortages whenever practicable. We are also monitoring and reacting to extended lead times on electronic components and utilizing a variety of strategies, including blanket orders, vendor-bonded inventories, extended commitments to our supply base, and seeking alternative suppliers. Additionally, we have taken actions to increase regular contact with our essential vendors and increased our forecasting horizon for our products to help us better manage our supply chain. In some cases, we are working with our vendors to help them procure components. Our strategies to counteract the impact of the pandemic and the related supply chain dislocations have significantly increased the amount of inventory we maintain to support our product sales. We have also experienced several situations where component shortages and scarcity have required us to pay significantly higher costs to obtain those components, particularly electronic components and circuit board assemblies. We will continue to monitor our supply chain going forward and update our mitigation strategies as we determine appropriate. We are not able to predict how current supply chain difficulties will develop in the future, and if the steps we are taking are not effective, it could have a material adverse impact on our results of operations.

Product Identification Update

Our Product Identification business has been negatively impacted by the

COVID-19

pandemic because our ability to meet with customers to demonstrate our products at trade shows and

on-site

in their facilities has been curtailed. We have partially countered this through a variety of virtual, online selling and digital marketing strategies, but the degree to which this will be successful to mitigate the lack of

face-to-face

selling is unclear.

Test & Measurement Update

The aerospace industry, which we serve through our aerospace product line, has also been significantly disrupted by the

COVID-19

pandemic, both inside and outside of the United States because of the severe decline in the demand for air travel and aircraft and a general curtailment of aircraft production rates. This has had a material adverse impact on our financial results. While air travel demand appears to have substantially recovered, it remains unclear whether and to what extent recent aircraft production demand increases will continue. The secondary impacts of the demand decline and resulting financial losses on the economic structure of the airline industry could become a negative factor for demand for aircraft due to industry consolidation. Individually or in combination, these factors may continue to have a material adverse impact on our business operations and financial results.

Results of Operations

Three Months Ended July 30, 2022 vs. Three Months Ended July 31, 2021

Revenue by segment and current quarter percentage change over the prior year for the three months ended July 30, 2022 and July 31, 2021 were:


(Dollars in thousands)	July 30, 2022		As a % of Revenue			July 31, 2021		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	23,382		72.5	%	$	23,492		78.7	%		(0.5	)%
T&M		8,877		27.5	%		6,353		21.3	%		39.7	%

Total	$	32,259		100.0	%	$	29,845		100.0	%		8.1	%

Revenue for the current quarter was $32.3 million, representing an 8.1% increase compared to the prior year’s second quarter revenue of $29.8 million. Revenue through domestic channels for the second quarter of the current year was $19.0 million, an increase of 10.8% from the prior year’s second quarter. International revenue for the second quarter of the current year was $13.2 million, representing 41.0% of our second quarter revenue and reflecting a 4.4% increase from the previous year’s second quarter. Current year’s second quarter international revenue includes an unfavorable foreign exchange rate impact of $1.1 million.

Hardware revenue in the current quarter was $8.6 million, a 9.6% increase compared to the prior year’s second quarter revenue of $7.9 million. The increase is mainly attributable to the T&M segment, as hardware revenue for that segment increased 22.4% compared to the second quarter of the prior year. The increase in T&M segment hardware sales primarily resulted from an increase in sales of the aerospace printer product line. The increase in current quarter hardware sales was partially offset by an overall 3.3% decrease in hardware sales in the PI segment, as well as a decrease in sales of certain data recorders in the T&M product group.

Supplies revenue in the current quarter was $19.2 million, a 2.6% increase compared to the prior year’s second quarter supplies revenue of $18.7 million. The increase in the current quarter is primarily attributable to the higher paper supplies sales in the aerospace product group in the T&M segment and to a lesser extent, the overall increased revenue from PI segment supply sales.

Service and other revenues of $4.5 million in the current quarter increased 35.5% compared to second quarter revenue of $3.3 million in the prior year. The increase is due primarily to increased part sales and repair revenue related to the aerospace printer product line in the T&M segment, slightly offset by an overall decrease in parts sales and repair revenue in the Product Identification segment.

Current year second quarter gross profit was $11.4 million, a 10.5% decrease compared to the prior year’s second quarter gross profit of $12.7 million. Our current quarter gross profit margin of 35.3% reflects a 7.3 percentage point decrease from the prior year’s second quarter gross profit margin of 42.6%. The lower gross profit and related profit margin for the current quarter compared to the prior year’s second quarter is primarily attributable to increased manufacturing and period costs and the impact of the employee retention credit (“ERC”), a refundable tax credit against certain employer taxes as provided under the CARES Act, which reduced manufacturing payroll taxes, a component of cost of revenue, by $1.7 million in the second quarter of the prior year.

Operating expenses for the current quarter were $10.1 million, a 9.5% increase compared to the prior year’s second quarter operating expenses of $9.3 million. Specifically, current quarter selling and marketing expenses were $6.0 million, an 18.2% increase compared to the second quarter of the prior year. The increase in the current quarter’s selling and marketing expenses was primarily due to an increase in payroll taxes in the second quarter of the current year as compared to the prior year’s second quarter payroll taxes which were decreased by $0.8 million by the ERC. The current quarter’s increase in selling and marketing expenses was also impacted by an increase in employee wages and travel and entertainment expenses, partially offset by a decrease in employee bonuses. Current quarter general and administrative expenses were $2.6 million, a 3.5% decrease compared to the second quarter of the prior year. The decrease in general and administrative expenses for the current quarter was primarily due to a decrease in employee bonuses and share based compensation expense. This decrease was partially offset by an increase in payroll taxes in the second quarter of the current year as compared to the prior year’s second quarter which decreased $0.3 million due to the ERC and an increase in current quarter outside service expenses. Research and development (“R&D”) expenses were $1.6 million in the current quarter, a 3.6% increase compared to the second quarter of the prior year. The current quarter increase is primarily due to higher employee wages and the impact of the ERC, which reduced manufacturing payroll taxes in the amount of $0.3 million in the second quarter of the prior year. The current quarter’s increase in R&D was partially offset by a decrease in employee bonuses and supply expenses. R&D spending as a percentage of revenue for the current quarter is 4.9% compared to 5.2% for the same period of the prior year.

Other expense in the second quarter of the current year was $0.4 million compared to other income of $4.3 million in the second quarter of the prior year. Current quarter other expense includes interest expense on debt and line of credit of $0.2 million and a net foreign exchange loss of $0.2 million. Other income for the second quarter of the prior year included $4.5 million related to the forgiveness of our PPP Loan and a net foreign exchange gain of $0.1 million, partially offset by interest expense on debt of $0.2 million and other expense of $0.1 million.

The provision for federal, state and foreign income taxes for the second quarter of the current year is $0.2 million, resulting in an effective tax rate of 27.4%. This compares to the prior year’s second quarter tax provision of $0.7 million, resulting in an effective tax rate of 9.1%. This rate was impacted by a $1.1 million tax benefit from the forgiveness of the PPP loan.

We reported net income of $0.6 million or $0.08 per diluted share for the second quarter of the current year. Net income for the prior year’s second quarter was $7.0 million or $0.96 per diluted share. Prior year second quarter results were impacted by income of $4.5 million ($4.4 million net of tax or $0.60 per diluted share) related to the gain on extinguishment of debt for the PPP Loan forgiveness and income of $3.1 million ($2.4 million net of tax or $0.32 per diluted share) related to the ERC. Return on revenue was 1.8% for the current quarter of fiscal 2023 compared to 23.5% for the prior year’s second quarter.

Six Months Ended July 30, 2022 vs. Six Months Ended July 31, 2021

Revenue by segment and current period percentage change over the prior year for the six months ended July 30, 2022 and July 31, 2021 were:


(Dollars in thousands)	July 30, 2022		As a % of Revenue			July 31, 2021		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	45,106		71.3	%	$	46,590		79.1	%		(3.2	)%
T&M		18,163		28.7	%		12,333		20.9	%		47.3	%

Total	$	63,269		100.0	%	$	58,923		100.0	%		7.4	%

Revenue for the first six months of the current year was $63.3 million, representing a 7.4% increase compared to the previous year’s first six months revenue. Revenue through domestic channels for the first half of the current year was $38.7 million, an increase of 14.2% from prior year’s domestic revenue of $33.9 million. International revenue for the first six months of the current year was $24.6 million, a 1.9% decrease from the previous year’s international revenue of $25.0 million. International revenue for the first six months of the current year reflected an unfavorable foreign exchange rate impact of $1.6 million.

Hardware revenue in the first six months of the current year was $17.9 million, a 15.5% increase compared to the prior year’s first six months hardware revenue of $15.5 million. The increase in hardware revenue is primarily due to a 45.4% increase in hardware sales in the T&M segment primarily attributable to higher aerospace printer and data recorder product line sales. The increase in current year revenue was partially offset by an overall decline in hardware sales in the PI segment.

Supplies revenue in the first half of the current year was $37.1 million, representing a 0.6% increase over the prior year’s first six months supplies revenue of $36.9 million. The increase in the current year’s supply revenue is primarily due to the increase in sales of aerospace product group paper supplies in the T&M segment partially offset by an overall decline in supplies sales in the PI segment.

Service and other revenues were $8.2 million in the first six months of the current year, a 26.3% increase compared to the prior year’s first six months service and other revenues of $6.5 million. The increase is due primarily to overall increased repair and parts revenue in the T&M segment, partially offset by a decline in repair and parts sales in the PI segment.

Current year first six months gross profit was $22.1 million, a 6.3% decrease from the prior year’s first six months gross profit of $23.6 million. Our gross profit margin of 34.9% in the current year reflects a 4.8 percentage point decrease from the prior year’s first six months gross profit margin of 40.1%. The lower gross profit and related profit margin for the current year compared to the prior year is primarily attributable to increased manufacturing and period costs and the impact of the ERC, which reduced manufacturing payroll taxes, a component of cost of revenue, in the amount of $1.7 million in the second quarter of the prior year.

Operating expenses for the first six months of the current fiscal year were $20.1 million, a 3.6% increase compared to the prior year’s first six months operating expenses of $19.4 million. Selling and marketing expenses for the current year of $11.9 million increased by 6.4% compared to the previous year’s first six months primarily due to an increase in payroll taxes in the second quarter of the current year related to the ERC, which reduced payroll taxes in the amount of $0.8 million in the second quarter of the prior year, as well as the current year increase in employee wages and benefits and travel and entertainment expense. The current year increase in selling and marketing expenses was partially offset by a decrease in employee bonuses. General and administrative expenses increased 2.5% to $5.1 million in the first six months of the current year compared to $5.0 million in the first six months of the prior year, primarily due to an increase in payroll taxes in the second quarter of the current year related to the ERC which reduced payroll taxes in the amount of $0.3 million in the second quarter of the prior year. Also contributing to the current year increase was an increase in outside service and depreciation expense, partially offset by a decrease in employee bonuses, share based compensation and advertising expenses. R&D spending in the first six months of the current year was $3.1 million, a 4.2% decrease compared to the prior year’s first six months spend of $3.3 million primarily due to a decrease in employee bonuses and supplies expenses partially offset by increases in employee wages, outside consulting fees and the impact of the ERC, which reduced manufacturing payroll taxes in the amount of $0.3 million in the second quarter of the prior year. Current year spending on R&D represents 4.9% of revenue compared to the prior year’s first six months level of 5.5%.

Other expense during the first six months of the current year was $0.7 million compared to other income of $3.9 million in the first six months of the previous year. Current year other expense includes interest expense on debt and the line of credit of $0.4 million, net foreign exchange loss of $0.4 million, offset by other income of $0.1 million. Other income for the first six months of the prior year included $4.5 million related to the forgiveness of our PPP Loan, partially offset by interest expense on debt of $0.4 million, net foreign exchange loss of $0.1 million, and other expense of $0.1 million.

We recognized $0.3 million of income tax expense for the first six months of the current fiscal year, resulting in an effective tax rate of 21.7%. We recognized $0.5 million of income tax expense for the first six months of the prior fiscal year, which reflects a $1.1 million tax benefit from the forgiveness of our PPP Loan, and results in a 5.8% effective tax rate.

We reported net income of $1.0 million, or $0.14 per diluted share, for the first six months of the current year. On a comparable basis, net income for the prior year’s first six months was $7.6 million, or $1.04 per diluted share. The results for the prior period were impacted by income of $4.5 million ($4.4 million net of tax or $0.61 per diluted share) related to the forgiveness of our PPP Loan and income of $3.1 million ($2.4 million net of tax or $0.33 per diluted share) related to the ERC. Return on revenue was 1.6% for the first six months of fiscal 2023 compared to 12.9% for the first six months of fiscal 2022.

Segment Analysis

We report two segments: Product Identification and Test & Measurement and evaluate segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended									Six Months Ended
	Revenue				Segment Operating Profit					Revenue				Segment Operating Profit
(In thousands)	July 30, 2022		July 31, 2021		July 30, 2022			July 31, 2021		July 30, 2022		July 31, 2021		July 30, 2022			July 31, 2021
Product Identification	$	23,382	$	23,492	$	1,644		$	4,406	$	45,106	$	46,590	$	3,058		$	7,134
T&M		8,877		6,353		2,162			1,710		18,163		12,333		4,072			2,060

Total	$	32,259	$	29,845		3,806			6,116	$	63,269	$	58,923		7,130			9,194

Corporate Expenses						2,571			2,664						5,131			5,008

Operating Income						1,235			3,452						1,999			4,186
Other Income (Expense), Net						(431	)		4,266						(710	)		3,897

Income Before Income Taxes						804			7,718						1,289			8,083
Income Tax Provision						220			699						280			471

Net Income					$	584		$	7,019					$	1,009		$	7,612

Product Identification

Revenue from the Product Identification segment decreased 0.5% in the second quarter of the current year, with revenue of $23.4 million compared to $23.5 million in the same period of the prior year. The slight overall decrease in current quarter revenue is due to a $0.3 million decrease in printer and part sales, offset by a $0.2 million increase in supply sales. Product Identification’s current quarter segment operating profit was $1.6 million, reflecting a profit margin of 7.0% and compares to the prior year’s second quarter segment profit of $4.4 million and related profit margin of 18.8%. The primary reason for the decline in operating margin is that the prior year’s second quarter included $1.4 million in net ERC related payroll tax credits that reduced manufacturing and operating costs. Excluding the impact of the ERC, the current year’s second quarter segment operating margin was also lower due to a slightly unfavorable sales mix, the effect on manufacturing and period costs of higher labor and supply chain costs, higher trade show and travel expenses, increased expense provisions for printers used for product demonstrations, and higher warranty and service charges related to mitigating defective ink damage to some of our installed printers.

Revenue from the Product Identification segment decreased 3.2% to $45.1 million in the first six months of the current year from $46.6 million in the same period of the prior year. The current year’s decrease is primarily due to an overall decrease in sales of hardware and supplies in this segment offset by increased sales of certain printer products and an increase in supply sales of ink jet products. Product Identification’s current year segment operating profit was $3.1 million with a profit margin of 6.8%, compared to the prior year’s segment operating profit of $7.1 million and related profit margin of 15.3 %. The primary reason for the decline in operating margin is that the same period for the prior year included $1.4 million in net ERC related payroll tax credits that reduced manufacturing and operating costs. Excluding the impact of the ERC, the current year’s second quarter segment operating margin was also lower due to a slightly unfavorable sales mix, the effect on manufacturing and period costs of higher labor and supply chain costs, higher trade show and travel expenses, increased expense provisions for printers used for product demonstrations, and higher warranty and service charges related to mitigating defective ink damage to some of our installed printers.

Test & Measurement—T&M

Revenue from the T&M segment was $8.9 million for the second quarter of the current fiscal year, representing a 39.7% increase compared to revenue of $6.4 million for the same period in the prior year. The increase in revenue for the current quarter was primarily attributable to the significantly higher volume of aerospace product group repairs and parts revenue and higher cockpit printer revenue and, to a lesser extent, increased paper sales. These increases are due to the rebound in air travel as the impact of COVID-19 lessens, and the increase in demand for new aircraft. The revenue increase for the second quarter is partially offset by the decline in the current quarter TMX hardware sales in T&M data acquisition products. T&M’s second quarter segment operating profit was $2.2 million, reflecting a profit margin of 24.4%, compared to the prior year’s segment operating profit of $1.7 million and related operating margin of 26.9%. Prior year’s second quarter included the impact of $0.8 million in net ERC related payroll tax credits that reduced manufacturing and operating costs. Excluding the impact of the ERC, the increase in segment operating profit was a result of slightly lower selling and marketing costs, the impact on gross margins of increased operating leverage on higher revenues, and a much more favorable mix of higher margin parts and repair revenues. However, these favorable impacts were significantly negatively offset by considerably higher component costs in certain aerospace printer models.

Revenue from the T&M segment was $18.2 million for the first six months of the current fiscal year, a 47.3% increase compared to sales of $12.3 million for the same period in the prior year. The increase in revenue for the current year was primarily attributable to higher cockpit printer revenue, significantly higher volume of aerospace product group repairs and parts revenue and, to a lesser extent, increased paper sales. These increases are due to the rebound in air travel as the impact of COVID-19 lessens, and the increase in demand for new aircraft. The current year’s increase in revenue is partially offset by the decline in current year TMX hardware sales in T&M data acquisition products. The segment’s first six months operating profit of $4.1 million resulted in a 22.4% profit margin compared to the prior year’s segment operating profit of $2.1 million and related operating margin of 16.7%. Prior year included the impact of $0.8 million in net ERC related payroll tax credits that reduced manufacturing and operating costs. Excluding the impact of the ERC, the increase in segment operating profit and margin was a result of slightly lower selling and marketing costs, the impact on gross margins of increased operating leverage on higher revenues, and a much more favorable mix of higher margin parts and repair revenues. However, these favorable impacts were significantly negatively offset by considerably higher component costs in certain aerospace printer models.

Financial Condition, Liquidity and Capital Resources

Overview

Historically, our primary sources of short-term liquidity have been cash generated from operating activities and borrowings under our revolving credit facility. These sources have also usually funded the majority of our capital expenditures and contractual contingent consideration obligations. We have funded acquisitions by borrowing under bank loan facilities.

On March 24, 2021, we entered into a First Amendment to our Amended & Restated Credit Agreement (the “Existing Credit Agreement”) with Bank of America, N.A., as lender (the “Lender”), and our subsidiaries, ANI ApS and TrojanLabel. The Amended & Restated Credit Agreement, which we entered into on July 30, 2020, amended and restated the Credit Agreement dated as of February 28, 2017, by and among us, ANI ApS and TrojanLabel and the Lender.

The Existing Credit Agreement provides for (i) a term loan in the principal amount of $10.0 million and (ii) a $22.5 million revolving credit facility available for general corporate purposes. At the closing of the First Amendment, we borrowed the entire $10.0 million term loan which was used to refinance in full the outstanding term loan under the Amended & Restated Credit Agreement. Under the Existing Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.

While we expected that as a result of the impact of the

COVID-19

pandemic, some of our customers would experience liquidity pressure and be unable to pay us for products on a timely basis, in general, our recent receivables collection experience has been consistent with our historical experience and a significant deterioration in receivables collection has not occurred.

In response to the

COVID-19

pandemic and related economic dislocation, we have implemented and will continue to implement a variety of expense reduction and cash preservation initiatives. On April 27, 2020, our board of directors suspended our quarterly cash dividend beginning with the second quarter of our fiscal year 2021.

At July 30, 2022, our cash and cash equivalents were $4.3 million. During the first six months of the current year, we borrowed $4.5 million on our revolving line of credit, and at July 30, 2022, we had $18.0 million available for borrowing under that facility. We believe that our available cash and credit facilities combined with our cash generated from operations will be sufficient to support our operating requirements including our capital expenditure commitments.

Indebtedness

Term Loan

The Existing Credit Agreement requires that the term loan be paid in quarterly installments on the last day of each of our fiscal quarters with the final payment due on September 30, 2025. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than September 30, 2025, at which time any outstanding revolving loans will be due and payable in full, and the revolving credit facility will terminate. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The Existing Credit Agreement includes an uncommitted accordion provision under which the term loan and/or revolving credit facility commitments may be increased in an aggregate principal amount not exceeding $10.0 million, subject to obtaining the agreement of the Lender and the satisfaction of certain other conditions.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Existing Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

The interest rates under the Existing Credit Agreement, as amended by the December 14, 2021 LIBOR Transition Amendment, are as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the BSBY Rate as defined in the LIBOR Amendment (or in the case of revolving credit loans denominated in Pounds Sterling, Euros or another currency other than U.S. Dollars, the SONIA Rate as defined in the LIBOR Amendment, EURIOBOR Rate as defined in the LIBOR Amendment, or the applicable quoted rate, respectively), plus a margin that varies within a range of 1.60% to 2.30% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the BSBY Rate, SONIA Rate, EURIBOR Rate or other applicable quoted rate plus 1.00% or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.30% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.30% based on our consolidated leverage ratio.

We must comply with various customary financial and

non-financial

covenants under the Existing Credit Agreement. The financial covenants under the Existing Credit Agreement consist of a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The minimum EBITDA, minimum consolidated asset coverage ratio, minimum liquidity and maximum capital expenditures covenants with which we were required to comply under the A&R Credit Agreement were eliminated by the First Amendment. The primary

non-financial

covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Existing Credit Agreement, certain of which provisions were modified by the First Amendment.

Our obligations under the Existing Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests held by our wholly-owned Danish subsidiary, ANI ApS), in our wholly-owned German subsidiary AstroNova GmbH, and in our wholly-owned French subsidiary AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island. Pursuant to the First Amendment, the guarantees of our obligations under the Amended & Restated Credit Agreement that were previously provided by ANI ApS and TrojanLabel were released.

Subsequent Event – Credit Agreement

In connection with the purchase of Astro Machine, on August 4, 2022, we entered into a Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”) the Lender. The Second Amendment amended the Existing Credit Agreement (the “Amended Credit Agreement”).

The Amended Credit Agreement provides for (i) a new term loan in the principal amount of $6.0 million, which term loan is in addition to the existing term loan outstanding under the Existing Credit Agreement in the principal amount of $9.0 million as of the effective date of the Second Amendment, and (ii) an increase in the aggregate principal amount of the revolving credit facility available to us from $22.5 million to $25.0 million. At the closing of the Second Amendment, we borrowed the entire $6.0 million term loan and $12.4 million under the revolving credit facility, and the proceeds of such borrowings were used in part to pay the purchase price payable under the Purchase Agreement and certain related transaction costs. We have since repaid $1.0 million of the amount borrowed under the revolving credit facility.

The Amended Credit Agreement requires that the term loan be paid in quarterly installments on the last day of each of our fiscal quarters over the term of the Amended Credit Agreement on the following repayment schedule: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2022 through July 31, 2023 is $375,000; and the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2023 through April 30, 2027 is $675,000. The entire remaining principal balance of the term loan is required to be paid on August 4, 2027. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than August 4, 2027, and any outstanding revolving loans thereunder will be due and payable in full, and the revolving credit facility will terminate, on such date. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The interest rates under the Amended Credit Agreement are as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the BSBY Rate as defined in the Amended Credit Agreement (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.50% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the BSBY Rate plus 1.00%, or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.50% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.35% based on our consolidated leverage ratio.

We must comply with various customary financial and

non-financial

covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio and a minimum consolidated asset coverage ratio. The primary

non-financial

covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on their capital stock, to repurchase or acquire their capital stock, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Second Amendment.

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests we hold in ANI ApS, AstroNova GmbH and AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island, and are guaranteed by, and secured by substantially all of the personal property assets of, Astro Machine.

PPP Loan

On May 6, 2020, we entered into a Loan Agreement with and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”), which was enacted on June 5, 2020.

The PPP Loan, which would have matured on May 6, 2022, was unsecured and bore interest at a rate of 1.0% per annum, accruing from the loan date. No payments were due on the PPP Loan until the date on which the lender determined the amount of the PPP Loan that is eligible for forgiveness.

On June 15, 2021, Greenwood notified us that the SBA approved our application for forgiveness of the entire $4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $4.5 million gain on extinguishment of debt in Other Income (Expense) in our condensed consolidated income statement for the three and six months ended July 31, 2021.

Cash Flow

Our statements of cash flows for the six months ended July 30, 2022 and July 31, 2021 are included on page 7 of this report. Net cash used by operating activities was $3.8 million for the first six months of fiscal 2023 compared to cash provided of $5.5 million for the same period of the previous year. The increase in net cash used by operations for the first six months of the current year is primarily cash used by working capital, as the combination of changes in accounts receivable, inventory, income taxes payable, accounts payable and accrued expenses decreased cash by $10.3 million for the first six months of fiscal 2022, compared to an increase to cash of $2.7 million for the same period in fiscal 2022. The decrease in cash used by operations for the first six months of fiscal 2023 was partially offset by the $3.1 million of ERC receivable received in the first quarter of the current year.

Our accounts receivable balance increased to $17.4 million at the end of the second quarter compared to $17.1 million at year end. Days sales outstanding for the six months of fiscal 2023 is 46 compared to 45 days at prior year end.

The inventory balance was $41.7 million at the end of the second quarter of fiscal 2023, a $7.1 million increase compared to $34.6 million at year end. The increase in our inventory balance is primarily due to difficulty in the supply chain environment, including long lead times to obtain components and supplies which has required us to increase our component and supply buffer stock to support the demands of our customers in our PI segment. We have also experienced increased inventory levels related to our T&M products to maintain our targeted inventory levels as a result of increased sales in that segment and part shortage issues. Inventory days on hand increased to 180 days at the end of the current quarter from 156 days at the prior year end.

The net cash position at July 30, 2022 was $4.3 million compared to the year end balance of $5.3 million. The decrease in the cash balance includes the impact of cash used from the working capital accounts, as discussed above. Additional cash outflows during the first six months of fiscal 2023 included principal payments on the long-term debt and the guaranteed royalty obligation of $0.3 million and $1.0 million, respectively, and cash used to acquire property, plant and equipment of $0.2 million, partially offset by current year borrowing under the revolving credit facility of $4.5 million.

Critical Accounting Policies, Estimates and Certain Other Matters

The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. We base these estimates and judgments on factors we believe to be relevant, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

The process of determining significant estimates is fact-specific and takes into account factors such as historical experience, current and expected economic conditions, product mix, and in some cases, actuarial and appraisal techniques. We constantly

re-evaluate

these significant factors and make adjustments where facts and circumstances dictate.

While we believe that the factors considered provide a meaningful basis for the accounting policies applied in the preparation of the condensed consolidated financial statements, we cannot guarantee that our estimates and assumptions will be accurate. As the determination of these estimates requires the exercise of judgment, actual results may differ from those estimates, and such differences may be material to our condensed consolidated financial statements. There have been no material changes to the application of critical accounting policies as disclosed in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2022.

Forward-Looking Statements

This Quarterly Report on Form

10-Q

may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial, industry and business conditions; (b) the impact of the ongoing

COVID-19

pandemic on us, our customers, our suppliers and the global economy; (c) declining demand in the test and measurement markets, especially defense and aerospace; (d) our ability to develop and introduce new products and achieve market acceptance of these products; (e) our dependence on contract manufactures and/or single or limited source suppliers; (f) competition in the specialty printer or data acquisition industries; (g) our ability to obtain adequate pricing for our products and control our cost structure; (h) our ability to adequately enforce and protect our intellectual property, defend against assertions of infringement or loss of certain licenses; (i) the risk of incurring liabilities as a result of installed product failures due to design or manufacturing defects (j) the risk of a material security breach of our information technology system or cybersecurity attack impacting our business and our relationship with customers; (k) our ability to attract, develop and retain key employees; (l) economic, political and other risks associated with international sales and operations and the impact of changes in foreign currency exchange rates on the results of operations; (m) changes in tax rates or exposure to additional income tax liabilities; (n) our ability to comply with our current credit agreement or secure alternative financing and to otherwise manage our indebtedness; (o) our ability to successfully integrate acquisitions and realize benefits from divestitures; (p) our ability to maintain adequate self-insurance accruals or insurance coverage for employee health care benefits; (q) our compliance with customer or regulators certifications and our compliance with certain governmental laws and regulations; and (r) other risks included under

“Item 1A-Risk

Factors” in our Annual Report on Form

10-K

for the fiscal year ended January 31, 2022. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

During the six months ended July 30, 2022, there were no material changes to our market risk disclosures as set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form

10-K

for the year ended January 31, 2022.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to

Rule 13a-15(b)

under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

There are no pending or threatened legal proceedings against us that we believe to be material to our financial position or results of operations.

Item 1A.

Risk Factors

This section augments and updates certain risk factors disclosed in Item 1A of Part I of our Annual Report on Form

10-K

for the year ended January 31, 2022 (the “Annual Report”). We are providing the following information regarding changes that have occurred to the previously disclosed risk factors in our Annual Report on

Form 10-K.

In addition to the other information in this Quarterly Report on Form

10-Q,

all risk factors should be carefully considered in evaluating us and our common stock. Any of these risks, many of which are beyond our control, could materially and adversely affect our financial condition, results of operations or cash flows, or cause our actual results to differ materially from those projected in any forward-looking statements. We may also face other risks and uncertainties that are not presently known, are not currently believed to be material, or are not identified below because they are common to all businesses. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. For more information, see “Forward-Looking Statements” elsewhere in this Quarterly Report.

There have been no material updates to the risk factors previously disclosed in our Annual Report on

Form 10-K

for the fiscal year ended January 31, 2022.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

During the second quarter of fiscal 2023, we made the following repurchases of our common stock:

Total Number
of Shares
Repurchased

Average
Price paid
Per Share

Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs

Maximum Number
of Shares That
May Be Purchased
Under The Plans
or Programs

May 1—May 31

—

June 1—June 30

—

July 1—July 31

—


	July 30, 2022			January 31, 2022
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	$	i 4,285		$	i 5,276
Accounts Receivable, net		i 17,382			i 17,124
Inventories, net		i 41,727			i 34,609
Employee Retention Credit Receivable		—			i 3,135
Prepaid Expenses and Other Current Assets		i 4,268			i 3,634

Total Current Assets		i 67,662			i 63,778
Property, Plant and Equipment, net		i 10,577			i 11,441
Intangible Assets, net		i 18,314			i 19,200
Goodwill		i 11,501			i 12,156
Deferred Tax Assets		i 5,582			i 5,591
Right of Use Assets		i 887			i 1,094
Other Assets		i 1,775			i 1,695

TOTAL ASSETS	$	i 116,298		$	i 114,955

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable	$	i 7,624		$	i 8,590
Accrued Compensation		i 2,437			i 3,512
Other Liabilities and Accrued Expenses		i 3,334			i 4,113
Revolving Line of Credit		i 4,500			—
Current Liability – Royalty Obligation		i 1,875			i 2,000
Current Portion of Long-Term Debt		i 1,000			i 1,000
Current Liability – Excess Royalty Payment Due		i 301			i 235
Income Taxes Payable		i 1,169			i 323
Deferred Revenue		i 281			i 262

Total Current Liabilities		i 22,521			i 20,035
Long-Term Debt, net of current portion		i 7,917			i 8,154
Royalty Obligation, net of current portion		i 3,611			i 4,361
Lease Liabilities, net of current portion		i 627			i 808
Income Taxes Payable		i 399			i 399
Deferred Tax Liabilities		i 127			i 186

TOTAL LIABILITIES		i 35,202			i 33,943
SHAREHOLDERS’ EQUITY
Common Stock, $ i i 0.05 / Par Value, Authorized i i 13,000,000 / shares; Issued i 10,659,491 shares and i 10,566,404 shares at July 30, 2022 and January 31, 2022, respectively		i 533			i 528
Additional Paid-in Capital		i 60,347			i 59,692
Retained Earnings		i 57,523			i 56,514
Treasury Stock, at Cost, i 3,341,030 and i 3,324,280 shares at July 30, 2022 and January 31, 2022, respectively		( i 34,223	)		( i 33,974	)
Accumulated Other Comprehensive Loss, net of tax		( i 3,084	)		( i 1,748	)

TOTAL SHAREHOLDERS’ EQUITY		i 81,096			i 81,012

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	i 116,298		$	i 114,955


	Six Months Ended
	July 30, 2022			July 31, 2021
Cash Flows from Operating Activities:
Net Income	$	i 1,009		$	i 7,612
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities:
Depreciation and Amortization		i 1,820			i 2,274
Amortization of Debt Issuance Costs		i 13			i 31
Share-Based Compensation		i 572			i 947
Loss on Disposal of Assets		i 6			—
Gain on Extinguishment of Debt		—			( i 4,466	)
Changes in Assets and Liabilities:
Accounts Receivable		( i 518	)		i 1,777
Other Receivable – Employee Retention Credit Receivable		i 3,135			( i 3,135	)
Inventories		( i 7,516	)		i 895
Income Taxes		i 65			( i 1,241	)
Accounts Payable and Accrued Expenses		( i 2,312	)		i 1,282
Other		( i 93	)		( i 483	)

Net Cash (Used) Provided by Operating Activities		( i 3,819	)		i 5,493
Cash Flows from Investing Activities:
Additions to Property, Plant and Equipment		( i 163	)		( i 1,162	)

Net Cash Used for Investing Activities		( i 163	)		( i 1,162	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans		i 69			i 43
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan		i 19			i 44
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock		( i 249	)		( i 354	)
Borrowings under Revolving Credit Facility		i 4,500			—
Payment of Minimum Guarantee Royalty Obligation		( i 1,000	)		( i 1,000	)
Proceeds from Long-Term Debt Borrowings		—			i 10,000
Payoff of Long-Term Debt		—			( i 12,576	)
Principal Payments of Long-Term Debt		( i 250	)		( i 375	)

Net Cash Provided (Used) for Financing Activities		i 3,089			( i 4,218	)

Effect of Exchange Rate Changes on Cash and Cash Equivalents		( i 98	)		( i 163	)

Net Decrease in Cash and Cash Equivalents		( i 991	)		( i 50	)
Cash and Cash Equivalents, Beginning of Period		i 5,276			i 11,439

Cash and Cash Equivalents, End of Period	$	i 4,285		$	i 11,389

Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	$	i 206		$	i 209
Cash Paid During the Period for Income Taxes, Net of Refunds	$	i 126		$	i 1,689


3A		Restated Articles of Incorporation of the Company and all amendments thereto, filed as Exhibit 3A to the Company’s Quarterly Report on Form 10-Q for the quarter ended April 30, 2016 and incorporated by reference herein.

3B		By-laws of the Company as amended to date, filed as Exhibit 3B to the Company’s Annual Report on Form 10-K/A for the fiscal year ended January 31, 2008 (File no. 000-13200) and incorporated by reference herein.

10.1		AstroNova, Inc. 2022 Employee Stock Purchase Plan, filed as Annex A to the AstroNova, Inc. Definitive Proxy Statement on Schedule 14A filed with the SEC on April 29, 2022 and incorporated by reference herein.

10.2		Equity Interest Purchase Agreement, dated as of August 4, 2022, by and among AstroNova, Inc., Astro Machine LLC and GSND Holding Corporation, filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, event date August 4, 2022, filed with the SEC on August 9, 2022 and incorporated by reference herein.

10.3		Purchase and Sale Agreement, dated as of August 4, 2022, between Astro Machine LLC and Selak Real Estate Limited Partnership, filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K, event date August 4, 2022, filed with the SEC on August 9, 2022 and incorporated by reference herein.

10.4		Second Amendment to Amended and Restated Credit Agreement, dated as of August 4, 2022, by and among AstroNova, Inc. and Bank of America, N.A. , filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K, event date August 4, 2022, filed with the SEC on August 9, 2022 and incorporated by reference herein.

31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)


	ASTRONOVA, INC.
	(Registrant)

Date: September 8, 2022	By	/s/ *Gregory A. Woods*
		Gregory A. Woods,
		President and Chief Executive Officer
		(Principal Executive Officer)

	By	/s/ *David S. Smith*
		David S. Smith,
		Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

This ‘10-Q’ Filing	Date	Other Filings

	8/4/27
	4/30/27
	9/30/25
	10/31/23
	7/31/23
	10/31/22
Filed on:	9/8/22
	8/4/22	8-K
For Period end:	7/30/22
	6/7/22
	5/6/22
	4/30/22	10-Q
	3/22/22	4
	1/31/22	10-K
	12/14/21
	7/31/21	10-Q
	6/30/21
	6/15/21	8-K
	5/1/21	10-Q
	3/24/21
	1/31/21	10-K
	12/31/20	SD
	12/27/20
	7/30/20	8-K
	6/5/20	8-K
	5/6/20
	4/27/20	8-K
	3/27/20	4, 8-K
	2/28/17	8-K
		List all Filings

AstroNova, Inc. – ‘10-Q’ for 7/30/22

On: Thursday, 9/8/22, at 2:19pm ET · For: 7/30/22 · Accession #: 1193125-22-240863 · File #: 0-13200

Previous ‘10-Q’: ‘10-Q’ on 6/8/22 for 4/30/22 · Next: ‘10-Q’ on 12/7/22 for 10/29/22 · Latest: ‘10-Q’ on 12/6/23 for 10/28/23 · 4 References:

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Quarterly Report

Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

4 Previous Filings that this Filing References

AstroNova, Inc. – ‘10-Q’ for 7/30/22

On: Thursday, 9/8/22, at 2:19pm ET · For: 7/30/22 · Accession #: 1193125-22-240863 · File #: 0-13200

Quarterly Report — Form 10-QFiling Table of Contents

‘10-Q’ — Quarterly ReportDocument Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

4 Previous Filings that this Filing References

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Quarterly Report

Document Table of Contents